This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Other parts of oropharynx
CD2_BENIGN_OROPHA_OTHER_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10
- Name in latin
- Neoplasma benignum oropharyngis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Other parts of oropharynx
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Other parts of oropharynx
- Benign neoplasm of mouth and pharynx
- Benign neoplasm of mouth and pharynx
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 324 | 193 | 131 |
| Unadjusted period prevalence (%) | 0.06 | 0.07 | 0.06 |
| Median age at first event (years) | 52.67 | 51.17 | 54.89 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 290
- Matched controls
- 2901
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D10.5
ICD-10 Finland
Benign neoplasm: Other parts of oropharynx
+∞
323.0
274
*
ENA10
NOMESCO Finland
Biopsy of pharynx
237.6
41.0
41
*
130
Kela drug reimbursment
Malignant tumour
+∞
32.9
31
*
UJC01
NOMESCO Finland
Scopy of lower throat
42.2
22.1
27
7
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
21.1
20
*
EHA10
NOMESCO Finland
Biopsy of palate
33.8
17.3
22
7
WF002
NOMESCO Finland
Radical radiotherapy
179.9
16.7
17
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
40.5
15.6
19
5
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
13.6
13
*
H02AB02
ATC
dexamethasone; systemic
14.8
13.5
22
16
EHB00
NOMESCO Finland
Excision of lesion of palate
52.5
13.0
15
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
12.6
12
*
A04AA02
ATC
granisetron; systemic, transdermal
135.6
12.5
13
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
39.4
12.3
15
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.7
11.7
100
476
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
11.5
11
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
124.7
11.5
12
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
4.9
11.0
36
81
A03FA01
ATC
metoclopramide; systemic, rectal
3.3
10.5
57
200
C61
ICD-10 Finland
Malignant neoplasm of prostate
113.9
10.5
11
*
ENB00
NOMESCO Finland
Excision or exploration of lesion of pharynx
+∞
10.5
10
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
41.6
10.0
12
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.7
10.0
28
53
JN4BD
NOMESCO Finland
Extensive body CT
5.6
9.8
28
54
JDB10
NOMESCO Finland
Percutaneous gastrostomy
31.2
9.5
12
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
9.4
9
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
9.4
9
*
115
Kela drug reimbursment
Breast cancer
+∞
9.4
9
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
9.4
9
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
9.4
9
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
9.4
9
*
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
12.0
9.2
16
14
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
38.0
9.1
11
*
D14.1
ICD-10 Finland
Benign neoplasm: Larynx
24.9
9.0
12
5
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
8.6
83
411
D10.9
ICD-10 Finland
Benign neoplasm: Pharynx, unspecified
92.6
8.5
9
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.8
8.4
35
100
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
8.4
8
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
8.4
8
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
8.4
8
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
8.4
8
*
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
+∞
8.4
8
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
8.4
8
*
D37.08
ICD-10 Finland
Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx
+∞
8.4
8
*
G47.3
ICD-10 Finland
Sleep apnoea
2.4
8.2
75
362
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
5.6
8.2
23
44
GBB00
NOMESCO Finland
Tracheostomy
15.6
7.8
12
8
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
12.3
7.7
13
11
EMA10
NOMESCO Finland
Biopsy of tonsil
82.1
7.4
8
*
2106A
ICD-9 Finland
Benign neoplasm of lip, oral cavity and pharynx, Other parts of oropharynx
+∞
7.3
7
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
30.8
7.2
9
*
XX3DW
NOMESCO Finland
Time consuming IT work
4.7
7.1
23
52
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
7.5
6.8
15
21
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.4
6.8
19
37
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
71.3
6.4
7
*
R21
ICPC
Throat symptom/complaint
2.2
6.4
66
336
R4190
NOMESCO Finland
Nutritional therapy
6.2
6.4
16
27
21068
ICD-8 Finland
Benign neoplasm of buccal cavity and pharynx, Other parts of oropharynx
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
WX707
NOMESCO Finland
Fiberoscopic intubation
+∞
6.3
6
*
D10.39
ICD-10 Finland
Benign tumor in other or unspecified part of oral cavity UNS
27.3
6.3
8
*
N02AA05
ATC
oxycodone; systemic
2.8
6.2
39
150
J38.1
ICD-10 Finland
Polyp of vocal cord and larynx
12.9
6.1
10
8
J39.2
ICD-10 Finland
Other diseases of pharynx
12.9
6.1
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
166
985
2.41
13.48
5.5
3.7
35.7
36.3
g/l
0.63
157
918
39
109
3.93
12.59
2.5
1.5
4.1
2.9
ug/l
0.41
31
82
173
1128
2.15
10.28
3.9
3.7
—
—
—
0
0
253
1935
2.40
9.85
8.4
5.4
77.4
74.0
u/l
0.86
241
1784
200
1396
2.13
9.74
9.6
6.6
4.1
4.1
e9/l
0.02
167
1231
127
753
2.13
9.48
3.8
2.0
2.4
2.3
mmol/l
0.27
113
638
182
1244
2.06
9.16
7.0
3.7
10.9
11.0
umol/l
0.07
176
1177
169
1126
2.05
9.11
8.5
5.9
1.2
1.2
mmol/l
0.74
143
959
17
35
5.07
7.97
1.4
1.1
—
—
—
0
0
201
1480
1.94
7.58
6.0
4.4
6.6
6.6
mmol/l
0.01
185
1362
129
846
1.87
6.72
3.1
2.8
—
—
—
0
0
150
1032
1.84
6.71
7.2
5.7
1.2
1.2
mmol/l
0.09
138
932
130
872
1.82
6.19
3.6
2.7
29.2
29.5
u/l
0.04
123
829
104
653
1.87
6.11
2.8
2.7
0.6
0.3
e6/l
0.58
74
481
90
540
1.92
6.07
2.8
1.9
—
—
—
0
0
48
229
2.29
5.92
2.3
1.9
31.0
32.8
u/l
0.23
37
189
241
1988
1.83
5.29
4.5
3.9
11.4
10.8
mm/h
0.33
225
1815
89
555
1.83
5.24
1.8
1.6
1.9
0.9
mg/l
0.87
67
427
35
154
2.43
5.17
3.7
3.6
4.5
4.6
pmol/l
0.22
28
136
19
61
3.25
5.00
3.6
3.6
—
—
—
0
0
71
424
1.86
4.76
3.6
2.0
2.4
2.4
mmol/l
0.29
62
367
298
2675
2.42
4.70
20.4
11.2
21.2
20.9
mg/l
0.08
260
2019
249
2117
1.76
4.42
4.7
3.9
14.7
14.7
pmol/l
0.07
224
1923
36
174
2.20
4.31
5.1
1.8
67.6
67.9
g/l
0.08
36
154
29
128
2.39
4.27
7.0
6.5
24.7
25.4
mmol/l
0.56
29
128
303
2762
2.50
4.21
21.6
13.2
139.6
139.8
mmol/l
1.03
298
2674
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
52
3.18
4.14
2.3
2.4
0.3
0.3
u/ml
—
7
30
303
2772
2.44
3.99
21.9
13.2
3.9
4.0
mmol/l
3.84
297
2686
59
351
1.83
3.97
3.2
2.2
15.1
14.2
umol/l
0.37
52
322
139
1045
1.58
3.87
2.1
1.9
91.3
96.1
pmol/l
0.72
67
534
60
362
1.81
3.86
2.0
1.8
—
—
—
0
0
282
2530
1.88
3.66
16.8
9.9
84.6
82.9
ml/min/173m2
0.57
228
2005
282
2536
1.86
3.54
5.8
4.6
2.0
2.3
mu/l
0.31
258
2321
112
815
1.57
3.52
2.8
2.3
58.9
56.5
u/l
0.32
102
752
78
521
1.65
3.48
1.8
1.5
—
—
—
0
0
52
310
1.81
3.47
3.3
2.2
2.3
2.3
g/l
0.24
46
291
159
1259
1.52
3.37
4.1
3.3
0.0
0.0
estimate
0.00
34
226
217
1836
1.55
3.37
3.4
3.0
51.4
44.9
u/l
0.66
206
1719
136
1042
1.53
3.36
2.1
2.3
74.6
76.2
nmol/l
0.30
119
928
162
1291
1.51
3.31
4.1
3.3
0.0
0.0
estimate
0.50
35
218
159
1269
1.50
3.19
5.8
4.5
0.0
0.0
estimate
0.00
36
222
41
233
1.87
3.19
4.0
2.8
—
—
—
0
0
16
61
2.71
3.18
2.9
2.2
1.2
1.5
mg/l
1.50
16
56
28
139
2.11
3.17
8.7
8.3
0.5
0.7
%
1.33
28
139
74
502
1.61
3.09
3.5
3.5
141.7
287.4
ng/l
0.56
54
366
6
8
7.61
3.06
1.3
1.0
—
—
—
0
0
6
8
7.61
3.06
1.3
1.0
—
—
—
0
0
28
141
2.08
3.06
8.5
8.3
1.1
1.6
%
1.93
28
141
277
2512
1.71
2.93
20.7
12.2
39.6
40.3
%
0.67
192
1856
27
137
2.06
2.90
3.7
3.5
1.2
2.2
mmol/l
0.51
21
104
27
138
2.04
2.85
1.7
1.4
—
—
—
0
0
206
1756
1.48
2.83
3.7
3.1
—
—
—
0
0
43
258
1.77
2.82
1.8
1.8
—
—
—
0
0
43
259
1.76
2.78
1.8
1.7
—
—
—
0
0
255
2276
1.57
2.76
22.4
13.4
13.7
13.5
%
0.61
249
2232
19
85
2.31
2.76
3.1
1.2
—
—
—
0
0
19
85
2.31
2.76
3.1
1.2
6.7
7.5
g/l
1.15
14
65
19
85
2.31
2.76
3.1
1.2
4.2
4.0
g/l
0.09
13
61
24
119
2.10
2.74
9.9
8.8
24.1
25.1
mmol/l
0.85
24
110
14
54
2.66
2.74
1.4
1.1
—
—
—
0
0
56
365
1.65
2.73
3.0
2.7
1.8
2.3
e6/l
0.17
28
178
46
288
1.70
2.61
3.3
2.3
26.0
25.2
%
0.16
37
252
36
211
1.79
2.56
8.9
9.9
120.3
124.5
g/l
0.66
36
204
5
7
7.23
2.55
1.4
1.0
—
—
—
0
0
5
7
7.23
2.55
1.4
1.0
—
—
—
0
0
308
2910
2.18
2.49
12.5
8.5
28.4
26.4
u/l
1.03
299
2798
5
8
6.33
2.38
2.2
1.9
—
—
—
0
0
8
24
3.39
2.19
1.0
1.0
—
—
—
0
0
6
14
4.34
2.16
1.0
1.4
—
—
—
0
0
92
703
1.43
2.15
3.4
2.9
1331.9
1165.8
ng/l
0.14
80
575
140
1154
1.38
2.09
3.5
2.7
137.1
109.9
ug/l
0.56
128
1074
100
779
1.41
2.09
2.2
2.1
169.8
250.1
u/l
0.43
89
734
7
20
3.55
2.06
1.0
1.1
—
—
—
0
0
78
584
1.44
2.02
1.2
1.3
0.6
1.7
u/ml
1.84
17
162
65
470
1.48
2.02
1.8
1.7
1406.0
1199.5
nmol/l
0.94
42
358
7
21
3.38
1.97
1.0
1.2
—
—
—
0
0
5
11
4.60
1.95
4.6
1.4
29.6
18.2
ug/l
—
5
11
85
651
1.41
1.95
2.9
2.3
10310.2
10032.9
umol/l
0.01
74
568
19
99
1.98
1.94
2.2
1.7
—
212.5
—
0
8
17
86
2.03
1.88
2.2
1.7
—
—
—
0
0
17
86
2.03
1.88
1.0
1.1
—
—
—
0
0
17
86
2.03
1.88
1.0
1.1
—
—
—
0
0
57
409
1.48
1.84
3.0
2.5
0.7
0.9
e6/l
0.29
29
223
13
61
2.18
1.74
1.5
1.3
—
—
—
0
0
22
126
1.80
1.73
2.0
1.7
—
—
—
0
0
14
68
2.11
1.73
2.0
1.9
5.2
7.1
iu/l
—
6
28
5
13
3.89
1.72
4.4
2.5
2.3
3.9
nmol/l
—
5
13
84
662
1.36
1.61
4.3
3.7
0.0
0.0
estimate
0.00
36
223
92
736
1.35
1.60
1.7
1.7
1.6
1.4
mmol/l
0.90
79
629
6
20
3.04
1.59
1.5
2.4
—
—
—
0
0
15
78
1.97
1.57
1.4
1.4
—
—
—
0
0
45
320
1.47
1.53
4.9
6.2
—
—
—
0
0
30
197
1.58
1.46
1.2
1.2
97.5
119.5
iu/ml
—
6
74
117
985
1.29
1.40
5.2
3.4
20.4
74.5
ng/l
0.82
76
646
11
53
2.11
1.40
2.5
2.1
3.6
4.2
g/l
0.44
11
53
7
29
2.44
1.40
1.9
2.3
—
637.4
—
0
5
66
517
1.35
1.31
1.6
1.7
446.0
431.6
pmol/l
0.17
48
433
269
2535
1.36
1.27
6.2
5.7
40.2
39.5
mmol/mol
0.52
247
2371
116
987
1.27
1.26
4.5
3.4
—
—
—
0
0
9
45
2.03
1.24
1.2
1.4
—
—
—
0
0
9
45
2.03
1.24
1.2
1.4
—
—
—
0
0
10
49
2.07
1.23
3.2
3.8
56.1
59.2
%
—
10
49
5
19
2.66
1.22
1.0
1.4
1.9
1.9
mmol/l
—
5
19
281
2671
1.39
1.22
5.1
4.4
6.0
5.9
mmol/l
0.95
257
2442
27
183
1.52
1.18
1.7
2.3
9.6
14.0
nmol/l
2.07
22
167
22
143
1.58
1.15
1.5
1.3
—
—
—
0
0
43
323
1.38
1.12
2.3
2.1
—
—
—
0
0
7
31
2.29
1.11
1.4
1.0
—
—
—
0
0
7
31
2.29
1.11
1.4
1.0
—
—
—
0
0
7
31
2.29
1.11
1.4
1.0
—
—
—
0
0
7
31
2.29
1.11
1.4
1.0
—
—
—
0
0
7
31
2.29
1.11
1.4
1.0
—
—
—
0
0
31
220
1.45
1.10
1.8
2.4
2.4
6.1
ug/l
5.07
22
196
11
61
1.83
0.99
1.4
1.4
—
—
—
0
0
33
244
1.39
0.95
2.5
1.9
364.0
366.3
nmol/l
0.03
33
221
38
289
1.36
0.93
2.3
2.0
—
—
—
0
0
14
87
1.64
0.89
1.7
1.3
325.4
278.0
miu/ml
—
5
44
283
2721
1.32
0.88
4.8
4.3
1.4
1.5
mmol/l
1.44
260
2532
25
179
1.43
0.87
3.9
3.8
67.2
82.9
ng/l
0.87
25
156
12
72
1.69
0.86
2.3
1.9
—
—
—
0
0
8
45
1.80
0.85
1.0
1.4
—
—
—
0
0
6
31
1.95
0.85
1.2
1.4
—
—
—
0
0
6
31
1.95
0.85
1.5
1.0
—
—
—
0
0
18
121
1.52
0.84
1.9
2.7
0.4
0.1
e6/l
0.47
18
114
10
57
1.78
0.84
1.3
1.1
—
—
—
0
0
11
65
1.72
0.83
1.3
1.1
—
—
—
0
0
8
47
1.72
0.81
1.6
1.3
—
—
—
0
0
284
2741
1.29
0.78
4.8
4.4
4.7
4.7
mmol/l
0.16
265
2561
13
84
1.57
0.73
2.2
1.6
—
—
—
0
0
24
178
1.38
0.71
2.3
1.9
—
—
—
0
0
5
26
1.94
0.71
1.0
1.3
—
—
—
0
0
14
93
1.53
0.70
2.0
1.6
—
—
—
0
0
58
488
1.23
0.69
1.2
1.3
20.4
38.2
iu/ml
1.03
11
148
7
42
1.68
0.69
1.3
1.1
—
—
—
0
0
88
774
1.19
0.67
4.9
3.7
1.8
1.9
ug/l
0.16
75
694
5
28
1.80
0.66
1.0
1.1
—
—
—
0
0
69
595
1.20
0.65
2.5
2.0
2.5
3.0
mg/l
1.48
60
503
5
29
1.74
0.64
1.0
1.4
—
—
—
0
0
0
20
0.00
0.60
0.0
1.9
—
6.9
—
0
11
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
8
52
1.55
0.60
5.5
2.8
23.1
25.3
mmol/l
—
8
46
19
140
1.38
0.60
1.5
1.4
—
—
—
0
0
286
2784
1.23
0.55
5.5
4.9
2.8
2.8
mmol/l
0.15
265
2584
6
38
1.59
0.54
1.2
1.1
—
—
—
0
0
6
38
1.59
0.54
1.0
1.2
—
—
—
0
0
18
134
1.36
0.54
1.7
1.8
—
—
—
0
0
6
39
1.55
0.53
1.0
1.0
—
—
—
0
0
18
135
1.35
0.52
1.1
1.0
—
—
—
0
0
24
191
1.28
0.48
2.4
1.8
73.7
68.8
ml/min/173m2
—
7
69
0
15
0.00
0.41
0.0
2.8
—
800.0
—
0
15
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
5
34
1.48
0.40
1.0
1.1
—
—
—
0
0
5
34
1.48
0.40
1.0
1.4
—
—
—
0
0
39
336
1.18
0.40
4.8
4.5
29.0
31.7
%
0.63
29
218
10
71
1.42
0.39
1.1
1.3
—
—
—
0
0
5
35
1.44
0.39
1.0
1.1
—
—
—
0
0
14
107
1.32
0.38
1.2
2.2
—
—
—
0
0
9
71
1.28
0.36
1.7
1.6
—
—
—
0
0
6
43
1.40
0.35
1.0
1.4
—
—
—
0
0
6
43
1.40
0.35
1.0
1.7
—
—
—
0
0
270
2639
1.14
0.35
4.4
3.9
1.4
1.3
mmol/l
1.40
248
2435
6
45
1.34
0.34
1.2
1.4
—
—
—
0
0
65
593
1.12
0.32
1.7
1.5
20.1
21.0
nmol/l
0.20
58
515
12
93
1.30
0.30
2.7
1.6
—
—
—
0
0
8
63
1.28
0.28
2.0
1.8
—
—
—
0
0
19
161
1.19
0.24
1.6
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
1519.1
—
0
11
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
2.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
9.1
—
0
13
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
5
69
0.72
0.17
1.0
1.3
—
10.6
—
0
8
11
92
1.20
0.16
3.3
2.6
583.3
3640.2
u/l
—
5
33
51
479
1.08
0.15
1.2
1.3
7.0
10.9
u/ml
0.35
16
186
16
141
1.14
0.14
7.6
10.3
26.3
25.0
mmol/l
0.83
16
132
5
48
1.04
0.09
2.2
1.6
—
—
—
0
0
44
461
0.95
0.09
1.3
1.5
—
—
—
0
0
12
107
1.13
0.08
1.3
1.5
—
—
—
0
0
14
129
1.09
0.05
2.9
2.2
1.5
1.3
%
0.24
14
129
46
445
1.04
0.05
2.8
2.5
0.7
0.7
ug/l
0.26
30
282
27
282
0.95
0.04
2.1
1.7
—
—
—
0
0
61
621
0.98
0.03
4.5
3.6
20.7
24.2
%
1.31
30
276
5
49
1.02
0.00
1.6
1.8
—
—
—
0
0
9
92
0.98
0.00
1.3
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
9
92
0.98
0.00
1.3
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
7
76
0.92
0.00
1.3
1.3
—
40.8
—
0
7
5
53
0.94
0.00
2.4
3.9
12.4
20.7
mg/l
—
5
32
9
95
0.95
0.00
1.6
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
9
92
0.98
0.00
1.3
1.5
—
—
—
0
0
9
97
0.93
0.00
1.3
1.4
—
—
—
0
0
6
59
1.02
0.00
1.5
1.5
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
56
0.89
0.00
3.8
1.3
52.0
61.8
pmol/l
—
5
56
9
92
0.98
0.00
1.3
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_OROPHA_OTHER_EXALLC – Benign neoplasm: Other parts of oropharynx
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).